PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
10.26434/chemrxiv.123872902020Druggability for COVID19 – in Silico Discovery of Potential Drug Compounds Against Nucleocapsid (N) Protein of SARS-CoV-2Manisha Ray, Saurav Sarkar, Surya Narayan Rathhttps://ndownloader.figshare.com/files/22824437
10.26434/chemrxiv.12387290.v12020Druggability for COVID19 – in Silico Discovery of Potential Drug Compounds Against Nucleocapsid (N) Protein of SARS-CoV-2Manisha Ray, Saurav Sarkar, Surya Narayan Rathhttps://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74be09abda29d90f8d17c/original/druggability-for-covid19-in-silico-discovery-of-potential-drug-compounds-against-nucleocapsid-n-protein-of-sars-co-v-2.pdf
Genomics & Informatics10.5808/gi.2020.18.4.e432020184e43Druggability for COVID-19: in silico discovery of potential drug compounds against nucleocapsid (N) protein of SARS-CoV-2Manisha Ray, Saurav Sarkar, Surya Narayan Rathhttp://genominfo.org/upload/pdf/gi-2020-18-4-e43.pdf, http://genominfo.org/journal/view.php?doi=10.5808/GI.2020.18.4.e43, http://genominfo.org/upload/pdf/gi-2020-18-4-e43.pdf
10.21203/rs.3.rs-512249/v22021Discovery of Potential Compounds Against SARS-COV-2 Based on 3clpro/Rdrp Dual-Target an in Silico Approachhttps://www.researchsquare.com/article/rs-512249/v2, https://www.researchsquare.com/article/rs-512249/v2.html
10.26434/chemrxiv.126118612020Drug Repurposing Commonly Against Dengue Virus Capsid and SARS-CoV-2 Nucleocapsid: An in Silico ApproachDebica Mukherjee, Rupesh Roy, UPASANA RAYhttps://ndownloader.figshare.com/files/23858138
10.26434/chemrxiv.128576782021Drug Repurposing for Coronavirus (COVID-19): In Silico Screening of Known Drugs Against the SARS-CoV-2 Spike Protein Bound to Angiotensin Converting Enzyme 2 (ACE2) (6M0J)Konstantinos Kalamatianoshttps://ndownloader.figshare.com/files/26678228
10.21203/rs.3.rs-19589/v12020In silico elucidation revealed SARS CoV and MERS CoV Drug Compounds could be Potential Therapeutic Candidates against Post Fusion Core (S2) Protein of Novel Coronavirus (2019-nCov)Zainab Ayaz, Bibi Zainab, Arshad Mehmood Abbasihttps://www.researchsquare.com/article/rs-19589/v1, https://www.researchsquare.com/article/rs-19589/v1.html
10.26434/chemrxiv.12611861.v22020Drug Repurposing Commonly Against Dengue Virus Capsid and SARS-CoV-2 Nucleocapsid: An in Silico ApproachDebica Mukherjee, Rupesh Roy, UPASANA RAYhttps://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74df8f96a002ee0287a35/original/drug-repurposing-commonly-against-dengue-virus-capsid-and-sars-co-v-2-nucleocapsid-an-in-silico-approach.pdf
10.26434/chemrxiv.12611861.v12020Drug Repurposing Commonly Against Dengue Virus Capsid and SARS-CoV-2 Nucleocapsid: An in Silico ApproachDebica Mukherjee, Rupesh Roy, UPASANA RAYhttps://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74db7842e651f34db3504/original/drug-repurposing-commonly-against-dengue-virus-capsid-and-sars-co-v-2-nucleocapsid-an-in-silico-approach.pdf
10.26434/chemrxiv-2021-v0b70-v42021Drug Repurposing for Coronavirus (COVID-19): In Silico Screening of Known Drugs Against the SARS-CoV-2 Spike Protein Bound to Angiotensin Converting Enzyme 2 (ACE2) (6M0J)Konstantinos Kalamatianoshttps://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60f44e7b78578781d96a856e/original/drug-repurposing-for-coronavirus-covid-19-in-silico-screening-of-known-drugs-against-the-sars-co-v-2-spike-protein-bound-to-angiotensin-converting-enzyme-2-ace2-6m0j.pdf